Bart J. van Vlijmen

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

Bart J. van Vlijmen, Arn M. J. M. van den Maagdenberg, Marion J. Gijbels et al. · Journal of Clinical Investigation · 1994 · 250 citations · Full text

Nutrition, Apolipoprotein E3-leiden, Diet-induced Hyperlipoproteinemia +17

Macrophage LRP1 contributes to the clearance of von Willebrand factor

Ghasem Rastegarlari, Julie Pegon, Caterina Casari et al. · Blood · 2012 · 120 citations · Full text

Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.

Bart J. van Vlijmen, H. Belinda van 't Hof, M.J.T.M. Mol et al. · Journal of Clinical Investigation · 1996 · 92 citations · Full text

Apolipoprotein E3-leiden, Genetics, Hyperlipidemia +21

Key Role of Platelet Procoagulant Activity in Tissue Factor‐and Collagen‐Dependent Thrombus Formation in Arterioles and Venules <i>In Vivo</i> Differential Sensitivity to Thrombin Inhibition

Marijke J. E. Kuijpers, Imke C.A. Munnix, Judith M.E.M. Cosemans et al. · Microcirculation · 2008 · 65 citations

Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.

Bart J. van Vlijmen, Neil Pearce, Martin O. Bergö et al. · PubMed · 1998 · 31 citations

Test Model, Genetic Epidemiology, Pathology +23